First Light Asset Management »

Caris Life Sciences shares owned by First Light Asset Management

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 404k 29.42
2025-06-30 $11M 443k 25.39

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Performant Healthcare Common Stocks (PHLT)
Centessa Pharmaceuticals Common Stocks (CNTA)
Neogenomics Common Stocks (NEO)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Health Catalyst Common Stocks (HCAT)
Palvella Therapeutics Common Stocks (PVLA)
Twist Bioscience Corporation Common Stocks (TWST)
Lenz Therapeutics Common Stocks (LENZ)
Organogenesis Holdings Common Stocks (ORGO)
Atricure Common Stocks (ATRC)
Anaptys Bio Common Stocks (ANAB)
Si-bone Common Stocks (SIBN)
Cidara Therapeutics Common Stocks (CDTX)

View all positions for First Light Asset Management

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences